US Patent Issued to Dyne Therapeutics on Sept. 22 for "Muscle-targeting complexes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,007, issued on Sept. 22, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.). "Muscle-targeting complexes and uses thereof" was invent... Read More

US Patent Issued to Shandong Boan Biotechnology on Sept. 22 for "CLDN18.2/CD3 bispecific antibodies for the therapy of CLDN18.2-expressing solid tumors" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,008, issued on Sept. 22, was assigned to Shandong Boan Biotechnology Co. Ltd. (Yantai, China). "CLDN18.2/CD3 bispecific antibodies for the... Read More

US Patent Issued to EVOPOINT BIOSCIENCES on Sept. 22 for "Antibody, antibody-drug conjugate thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,009, issued on Sept. 22, was assigned to EVOPOINT BIOSCIENCES Co. LTD. (China). "Antibody, antibody-drug conjugate thereof and use thereof... Read More

US Patent Issued to First Tracks Biotherapeutics on Sept. 22 for "PD-1 agonist and method of using same" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,010, issued on Sept. 22, was assigned to First Tracks Biotherapeutics Inc. (San Diego). "PD-1 agonist and method of using same" was invent... Read More

US Patent Issued to Verseau Therapeutics on Sept. 22 for "Anti-VSIG4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,011, issued on Sept. 22, was assigned to Verseau Therapeutics Inc. (Bedford, Mass.). "Anti-VSIG4 compositions and methods for modulating m... Read More

US Patent Issued to SUNSHINE LAKE PHARMA on Sept. 22 for "Humanized anti-TrkA antibodies and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,012, issued on Sept. 22, was assigned to SUNSHINE LAKE PHARMA Co. LTD. (Dongguan, China). "Humanized anti-TrkA antibodies and uses thereof... Read More

US Patent Issued to Horizon Therapeutics Ireland DAC on Sept. 22 for "IGF1R antibodies" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,013, issued on Sept. 22, was assigned to Horizon Therapeutics Ireland DAC (Dublin). "IGF1R antibodies" was invented by Christopher Davidso... Read More

US Patent Issued to FRESENIUS KABI DEUTSCHLAND on Sept. 22 for "Liquid pharmaceutical composition comprising an anti-il-6 receptor antibody" (Italian Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,014, issued on Sept. 22, was assigned to FRESENIUS KABI DEUTSCHLAND GMBH (Bad Homburg, Germany). "Liquid pharmaceutical composition compri... Read More

US Patent Issued to Ichnos Sciences, Astria Therapeutics on Sept. 22 for "Affinity matured anti-OX40 antibodies and use thereof" (Swiss, American Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,015, issued on Sept. 22, was assigned to Ichnos Sciences SA (La Chaux-de-Fonds, Switzerland) and Astria Therapeutics Inc. (Boston). "Affin... Read More

US Patent Issued to Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, National Center for Nanoscience and Technology on Sept. 22 for "Polypeptide that specifically binding to CD123 protein, polypeptide complex, co-delivery system and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,016, issued on Sept. 22, was assigned to Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (Beijing) and National Cen... Read More

• ««
• «
• 73799
• 73800
• 73801
• 73802
• 73803
• 73804
• 73805
• 73806
• 73807
• 73808
• »
• »»